Pharmaceutical Filtration Market
Pharmaceutical Filtration Market Global Industry Assessment & Forecast
- By Filters Membrane Filters, Depth Filters, Other Filters
- By Systems Single Use, Reusable
- By Technique Microfiltration, Ultrafiltration, Nanofiltration, Other Techniques
- By Type Sterile Filtration, Non-Sterile Filtration
- By Application Final Product Processing, Raw Material Filtration, Cell Separation, Water Purification, Air Purification
- By End Scale Manufacturing Scale, Pilot Scale, R&D Scale
- By Filtration Products Filtration Assemblies, Filter Holders, Filtration Accessories
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
|Forecast Years:||2022 - 2028|
|Historical Years:||2016 - 2021|
|Revenue 2021:||USD 10.1 Billion|
|Revenue 2028:||USD 24.9 Billion|
|Revenue CAGR (2022 - 2028):||16.3%|
|Fastest Growing Region (2022 - 2028)||Asia Pacific|
|Largest Region (2021):||North America|
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
The Global Pharmaceutical Filtration Market was valued at USD 10.1 Billion in 2021 and is anticipated to reach a value of USD 24.9 Billion by 2028. The Global Market is forecasted to grow to exhibit a Compound Annual Growth Rate (CAGR) of 16.3% over the forecast period.
Pharmaceutical Filtration Market Size, 2021 To 2028 (USD Billion)
Pharmaceutical Filtration is a separation technique that passes processed materials through a filtration membrane to remove unwanted particles. Growing emphasis on biologics and their development for the treatment of various diseases is expected to be a significant factor driving growth. One of the major features of nano-filtration membranes is their capacity to allow monovalent ions like sodium chloride to pass through while rejecting divalent and multivalent ions like sodium sulfate. Additionally, advanced therapeutic medications for chronic diseases such as cancer, diabetes, asthma, COPD, and arthritis are in high demand over the upcoming years.
Furthermore, manufacturing innovative biologics involves ultimate sterility and zero danger of contamination, requiring modern filtering products in the drug and biologics manufacturing process. Therefore, the leading players are now focused on strategies such as product innovations, mergers & acquisitions, new advancements, joint ventures, collaborations, and partnerships to improve their market position in the worldwide Pharmaceutical Filtration Market. Another significant factor driving growth is increased investment in biologics Research and Development (R&D) over the upcoming years. Also, the rapid adoption of novel treatment therapies like therapeutic proteins, monoclonal antibodies, and vaccines has resulted in a surge in the number of biotechnology and biopharmaceutical firms using filtration systems including membranes, cartridges, capsules, and other goods over the upcoming years.
The market's growth is projected to be limited by stringent regulatory reforms and the high cost of the filtration process. Besides, the high price of pharmaceutical filters and membrane fouling concerns make them challenging to use in bioPharmaceutical Filtration operations.
The Pharmaceutical Filtration Market is segmented based on Filters, Systems, Technique, Type, Application, End Scale, and Region. Based on the Filters segment, the market is sub-segmented into Membrane Filters, Depth Filters, and Other Filters. While based on the Systems segment market can be sub-segmented as Single-Use and Reusable filters. Based on the segment Technique, the market is sub-segmented as Microfiltration, Ultrafiltration, Nanofiltration, and Other Techniques. Based on the Type segment, the market can be further divided into sub-segments: Sterile Filtration and Non-Sterile Filtration. Furthermore, based on Applications, the market is divided into sub-segments Final Product Processing, Raw Material Filtration, Cell Separation, Water Purification, and Air Purification. Based on the End Scale of operation, the market is further sub-segmented as Manufacturing Scale, Pilot Scale, and Research and Development (R&D) Scale. Finally, based on the segment of Filtration Products, the market is sub-segmented as Filtration Assemblies, Filter Holders, and Filtration Accessories.
Below tree is interactive. You can click the nodes to get more information.
Based on Filters:
The Membrane Filters sub-segment holds the largest share in the market during the forecast period. Mixed Cellulose Ester (MCE) Membrane Filters coated cellulose acetate membrane filters, PTFE membrane filters, nylon membrane filters, PVDF membrane filters, and other membrane filters are among the several types of membrane filters available on the market. Increased adaptability and efficiency, lower operation costs, high performance, ease of use, and increased demand for Good Manufacturing Practices (GMP) and single-use technologies in the pharmaceutical business are all driving market growth over the upcoming years.
Based on Applications:
The Final Processing Product sub-segment is anticipated to grow at the highest rate during the forecast period. This growth is due to its extensive use in processing active pharmaceutical ingredients, protein purification, vaccine processing, antibody processing, and virus clearance. In addition, the adoption of innovative filters for final product processing is expected to increase as technology advances, such as cross-flow filtration, nano-fiber, and ultrafiltration technologies. Furthermore, the increasing use of biologics and other therapeutic proteins in the pharmaceutical and biopharmaceutical industries has boosted market growth by increasing the use of protein purification techniques.
North America is Projected to Grow at the Highest CAGR During the Forecast Period
North America is accounted to grow at the highest Compound Annual Growth Rate (CAGR) during the forecast period. The presence of vital biopharmaceutical manufacturing facilities in the region, the rising number of drug development projects, the presence of a well-established healthcare market, significant Research and Development (R&D) spending, and the presence of a well-established intellectual property system for innovative biologics account for the largest share of this segment. As a result, these businesses are forming partnerships and collaborations to achieve a larger market share. In addition, the surge in demand for Pharmaceutical Filtration products in Asia-Pacific gives attractive prospects for critical players in the Pharmaceutical Filtration Market. Other drivers include prominent manufacturers' increased focus on extending their regional presence in emerging Asia-Pacific countries to capitalize on solid growth potential in the market during the forecast period.
The key players in the Pharmaceutical Filtration Market include- Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US), Eaton Corporation PLC (US), Donaldson Company Inc. (US), Repligen Corporation (US), Porvair PLC (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), Meissner Filtration Products Inc. (US), Amazon Filters Ltd. (UK), Graver Technologies LLC (US), MMS AG (Switzerland), MANN+HUMMEL International GmbH & Co. KG (Germany), ErtelAlsop (US), Kasag Swiss AG (Switzerland), Freudenberg Filtration Technologies SE & Co. KG (Germany), Cole-Parmer Instrument Company LLC (US), Cantel Medical Corp. (US), Filtrox AG (Switzerland), Saint-Gobain Performance Plastics (France), Membrane Solutions (US).
Segmentation of Pharmaceutical Filtration Market:
|Regions & Countries Covered||
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis|
Frequently Asked Question
The global Pharmaceutical Filtration valued at USD 10.1 Billion in 2020 and is expected to reach USD 24.9 Billion in 2028 growing at a CAGR of 16.3%.
The prominent players in the market are Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US), Eaton Corporation PLC (US), Donaldson Company Inc. (US), Repligen Corporation (US), Porvair PLC (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), Meissner Filtration Products Inc. (US), Amazon Filters Ltd. (UK), Graver Technologies LLC (US), MMS AG (Switzerland), MANN+HUMMEL International GmbH & Co. KG (Germany), ErtelAlsop (US), Kasag Swiss AG (Switzerland), Freudenberg Filtration Technologies SE & Co. KG (Germany), Cole-Parmer Instrument Company LLC (US), Cantel Medical Corp. (US), Filtrox AG (Switzerland), Saint-Gobain Performance Plastics (France), Membrane Solutions (US).
The market is project to grow at a CAGR of 16.3% between 2021 and 2028.
The driving factors of the Pharmaceutical Filtration include
- Growth of biopharmaceutical industry to drive filtration products demand
North America was the leading regional segment of the Pharmaceutical Filtration in 2020.